{"id":"W4367056731","doi":"10.1016/j.jtha.2023.04.021","title":"News at XI: moving beyond factor Xa inhibitors","year":2023,"lang":"en","type":"review","venue":"Journal of Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Apixaban; Rivaroxaban; Edoxaban; Dabigatran; Medicine; Discovery and development of direct thrombin inhibitors; Pharmacology; Hemostasis; Thrombin; Warfarin; Internal medicine; Atrial fibrillation; Platelet","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00217374,0.001127349,0.002934066,0.002566985,0.0004431074,0.002541721,0.0009382895,0.004089396,0.01459171],"category_scores_gemma":[0.005663409,0.0004441792,0.001854467,0.002456477,0.0006271707,0.003387632,0.001333905,0.005687627,0.00421764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001193211,"about_ca_system_score_gemma":0.002383679,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001707582,"about_ca_topic_score_gemma":0.00475351,"domain_scores_codex":[0.9990282,0.0002277268,0.0002008705,0.00008334027,0.0003468899,0.0001129018],"domain_scores_gemma":[0.997174,0.001338754,0.0006027905,0.00005382418,0.0005505024,0.000280113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002761406,0.00004557308,0.0001850481,0.02476479,0.00049629,0.0001938324,0.00005749106,0.0001056162,0.0003618434,0.001847781,0.4913014,0.4803641],"study_design_scores_gemma":[0.0002541819,0.0001435318,0.000984274,0.02232657,0.0009502136,0.0004085481,0.00006428029,0.00005940625,0.00009432448,0.001328162,0.9733558,0.00003066599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006692576,0.9763736,0.00006991734,0.009931157,0.0120939,0.00001011546,0.00007548722,0.00001987145,0.00135913],"genre_scores_gemma":[0.0007762615,0.9563523,0.0001505093,0.02571611,0.01469786,0.00001875791,0.0001071957,0.000008234554,0.002172707],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01459171,"threshold_uncertainty_score":0.04881406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3035567583979344,"score_gpt":0.4410561727442059,"score_spread":0.1374994143462716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}